-
2
-
-
17944370018
-
International conference for the development of consensus on the diagnosis and treatment of ventilator-associated pneumonia
-
Rello J., Paiva J.A., Baraibar J., Barcenilla F., Bodi M., Castander D., et al. International conference for the development of consensus on the diagnosis and treatment of ventilator-associated pneumonia. Chest. 120:2001;955-970
-
(2001)
Chest
, vol.120
, pp. 955-970
-
-
Rello, J.1
Paiva, J.A.2
Baraibar, J.3
Barcenilla, F.4
Bodi, M.5
Castander, D.6
-
3
-
-
0033013154
-
Intravenous and oral mono- or combination-therapy in the treatment of severe infections: Ciprofloxacin vs standard antibiotic therapy
-
Krumpe P.E., Cohn S., Garreltes J., Ramirez J., Coulter H., Haverstock D., et al. Intravenous and oral mono- or combination-therapy in the treatment of severe infections: ciprofloxacin vs standard antibiotic therapy. J Antimicrob Chemother. 43:(suppl A):1999;117-128
-
(1999)
J Antimicrob Chemother
, vol.43
, Issue.SUPPL. A
, pp. 117-128
-
-
Krumpe, P.E.1
Cohn, S.2
Garreltes, J.3
Ramirez, J.4
Coulter, H.5
Haverstock, D.6
-
4
-
-
0031724015
-
Prospective randomized comparison of imipenem-cilastatin and pipéracilline-tazobactam in nosocomial pneumonia or peritonitis
-
Jaccard C., Troillet N., Harbarth S., Zanetti G., Aymon D., Schneider R., et al. Prospective randomized comparison of imipenem-cilastatin and pipéracilline-tazobactam in nosocomial pneumonia or peritonitis. Antimicrob Agents Chemother. 42:1998;2966-2972
-
(1998)
Antimicrob Agents Chemother
, vol.42
, pp. 2966-2972
-
-
Jaccard, C.1
Troillet, N.2
Harbarth, S.3
Zanetti, G.4
Aymon, D.5
Schneider, R.6
-
5
-
-
0035161036
-
Results of a clinical trial of clinafloxacin vs imipenem-cilastatin for intraabdominal infections
-
Solomkin J.S., Dellinger E.P., Christou N.C., Busuttil R.W. Results of a clinical trial of clinafloxacin vs imipenem-cilastatin for intraabdominal infections. Ann Surg. 233:2001;79-87
-
(2001)
Ann Surg
, vol.233
, pp. 79-87
-
-
Solomkin, J.S.1
Dellinger, E.P.2
Christou, N.C.3
Busuttil, R.W.4
-
6
-
-
0032450403
-
Ceftriaxone once daily for four weeks compared with ceftriaxone plus gentamicin once daily for two weeks for treatment of endocarditis due to penicillin-susceptible streptococci
-
Sexton D.J., Tenenbaum M.J., Wilson W.R., Steckelberg J.M., Tice A.D., Dismukes W., et al. Endocarditis Treatment Consortium Group. Ceftriaxone once daily for four weeks compared with ceftriaxone plus gentamicin once daily for two weeks for treatment of endocarditis due to penicillin-susceptible streptococci. Clin Infect Dis. 27:1998;1470-1474
-
(1998)
Clin Infect Dis
, vol.27
, pp. 1470-1474
-
-
Sexton, D.J.1
Tenenbaum, M.J.2
Wilson, W.R.3
Steckelberg, J.M.4
Tice, A.D.5
Dismukes, W.6
-
7
-
-
0037563090
-
ß lactam monotherapy vs ß lactam-aminoglycoside combination therapy for fever with neutropenia: Systematic review and meta-analysis
-
Paul M., Soares-Weiser K., Leibovici L. ß lactam monotherapy vs ß lactam-aminoglycoside combination therapy for fever with neutropenia: systematic review and meta-analysis. BMJ. 326:2003;1111-1119
-
(2003)
BMJ
, vol.326
, pp. 1111-1119
-
-
Paul, M.1
Soares-Weiser, K.2
Leibovici, L.3
-
8
-
-
0034723745
-
Recent experience with Pseudomonas aeruginosa bacteremia in patients with cancer: Retrospective analysis of 245 episodes
-
Chatzinikolaou I., Abi-Said D., Bodey G.P., Rolston S.V., Tarrand J.J., Samonis G. Recent experience with Pseudomonas aeruginosa bacteremia in patients with cancer: retrospective analysis of 245 episodes. Arch Intern Med. 160:2000;501-509
-
(2000)
Arch Intern Med
, vol.160
, pp. 501-509
-
-
Chatzinikolaou, I.1
Abi-Said, D.2
Bodey, G.P.3
Rolston, S.V.4
Tarrand, J.J.5
Samonis, G.6
-
9
-
-
0030858393
-
Outcomes of bacteremia in patients with cancer and neutropenia: Observations from two decades of epidemiological and clinical trials
-
Elting L.S., Rubenstein E.B., Rolston K.V., Bodey G.P. Outcomes of bacteremia in patients with cancer and neutropenia: observations from two decades of epidemiological and clinical trials. Clin Infect Dis. 25:1997;247-259
-
(1997)
Clin Infect Dis
, vol.25
, pp. 247-259
-
-
Elting, L.S.1
Rubenstein, E.B.2
Rolston, K.V.3
Bodey, G.P.4
-
10
-
-
0028287227
-
Propsective randomized comparison of imipenem monotherap with imipenem plus netilmicin for treatment of severe infections in nonneutropenic patients
-
Cometta A., Baumgatner J.D., Lew D., Zimmerli W., Pittet D., Chopart P., et al. Propsective randomized comparison of imipenem monotherap with imipenem plus netilmicin for treatment of severe infections in nonneutropenic patients. Antimicrob Agents Chemother. 38:1994;1309-1316
-
(1994)
Antimicrob Agents Chemother
, vol.38
, pp. 1309-1316
-
-
Cometta, A.1
Baumgatner, J.D.2
Lew, D.3
Zimmerli, W.4
Pittet, D.5
Chopart, P.6
-
11
-
-
0033915639
-
Monotherapy with a broad-spectrum betalactam is as effective as its combination with an aminoglycoside in treatment of severe generalized peritonitis: A multicenter randomized controlled trial
-
Dupont H., Carbon C., Carlet J. Monotherapy with a broad-spectrum betalactam is as effective as its combination with an aminoglycoside in treatment of severe generalized peritonitis: a multicenter randomized controlled trial. Antimicrob Agents Chemother. 44:2000;2028-2033
-
(2000)
Antimicrob Agents Chemother
, vol.44
, pp. 2028-2033
-
-
Dupont, H.1
Carbon, C.2
Carlet, J.3
-
12
-
-
0030970810
-
Monotherapy vs ß-lactam-aminoglycoside combination treatment for Gram-negative bacteremia : aa prospective, observational study
-
Leibovici L., Paul M., Poznanski O., Drucker M., Samra Z., Konigsberg H., et al. Monotherapy vs ß-lactam-aminoglycoside combination treatment for Gram-negative bacteremia : a prospective, observational study. Antimicrob Agents Chemother. 41:1997;1127-1133
-
(1997)
Antimicrob Agents Chemother
, vol.41
, pp. 1127-1133
-
-
Leibovici, L.1
Paul, M.2
Poznanski, O.3
Drucker, M.4
Samra, Z.5
Konigsberg, H.6
|